Back

State of the art non-coding RNAs and the control of neointima formation

29 August 2016 (16:30 - 16:48)
Organised by:
Congress Presentation Part of: Non-coding RNAs and the control of neointima formation Vascular remodelling ESC Premium Access ESC Congress 2016

About the speaker

Photo
Professor Ciro Indolfi

University of Calabria, Rende (Italy)

4 More presentations in this session

Presentation thumbnail
Intercellular transfer of miR-126-3p by endothelial microparticles reduces VSMC proliferation and limits neointima formation by inhibiting LRP6
Doctor F. Jansen (Cologne, DE)
Abstract Slides Video
Presentation thumbnail
Inhibition of microRNA-100 enhances neointima formation following carotid injury in mice by diminishing the expression of contractile marker proteins in vascular smooth muscle cells
Doctor S. Grundmann (Freiburg, DE)
Abstract
Presentation thumbnail
Local inhibition of microRNA 146a using a clinically applicable approach attenuates neointima formation
Miss L. Korte (Hannover, DE)
Abstract
Presentation thumbnail
Future direction for research in non-coding RNAs and the control of neointima formation.
Doctor I. Dykes (Liverpool, GB)
Slides Video

Access the full session

Session thumbnail
Non-coding RNAs and the control of neointima formation

The Event

Event poster

ESC Congress 2016

29 August 2016 16:30 CET
You may be interested in
thumbnail
Congress Presentation
RNA-based therapy in cardiovascular diseases
27 August 2023
thumbnail
Congress Presentation
INZ-701, a recombinant ENPP1-Fc protein, effectively treats and prevents neointimal proliferation in WT and ENPP1 Deficient mice
30 April 2022
thumbnail
Congress Presentation
Long noncoding RNA H19 is elevated in aortic valve stenosis and governs antigenic response and valvular endothelial cell phenotypes through endothelial to mesenchymal transition
26 August 2023
thumbnail
Congress Presentation
Potential implication of microRNA21 and matrix metalloproteinases in myocardial and arterial function in patients with coronary disease and type-2 diabetes at baseline and 1-year follow up
13 December 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources